Trial of Tirzepatide for the Treatment of Cannabis Use Disorder

Summary

The purpose of this randomized, double-blind, placebo-controlled, multi-site clinical trial is to evaluate the safety and efficacy of tirzepatide in a sample of 100 patients diagnosed with moderate or severe CUD by DSM-5 criteria.

Timeline

Start

2026-11-15

Primary completion

2028-03-15

Completion

2028-11-15

Drugs

Indications